- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07447973
Multimodal Deep Learning Model for Multi-task Diagnosis and Triage Suggestions of Ophthalmic Diseases
March 3, 2026 updated by: Guangdong Provincial People's Hospital
Development and Validation of Multimodal Deep Learning Model for Autonomous Diagnosis, Generative Reporting, and Specialist Referral in Ophthalmic Diseases: An International Multicenter Cohort Study
Accurate and comprehensive interpretation of anterior segment diseases from slit-lamp and smartphone photographs remains a clinical challenge due to the limited specificity and structure of existing Artificial Intelligence tools.
The purpose of this international, multicenter clinical trial is to developed and validated an agent-based framework that integrates vision-language models and large language models to enhance the diagnostic workflow of anterior segment diseases.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Honghua Yu
- Phone Number: +8618688888422
- Email: yuhonghua@gdph.org.cn
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510280
- Recruiting
- Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University
-
Contact:
- Honghua Yu
- Phone Number: +8618688888422
- Email: yuhonghua@gdph.org.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Individuals who have or do not have concerns related to their eyes.
Description
Inclusion Criteria:
- Informed consent obtained;
- Participants should be sufficiently able to read, write, and understand Chinese or English;
- For normal participants: individuals should have no concerns related to their eyes.
- For participants with eye-related chief complaints: individuals should have specific concerns or issues related to their eyes.
Exclusion Criteria:
- Incomplete clinical data to support final diagnosis;
- Patients who, in the opinion of the attending physician or clinical study staff, are too medically unstable to participate in the study safely.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Normal participants
Healthy individuals who have no concerns related to their eyes.
|
Multimodal Vision-language Model for Multi-task Diagnosis and Triage Suggestions of Ophthalmic Diseases Patients presenting with complaints of anterior segment diseases first complete a slit-lamp examination or take a mobile phone eye photograph.
A multimodal vision-language model uses patient-related images (such as selfies and eye exam photos) to make an intelligent diagnosis.
The diagnosis is kept private.
The patient then seeks medical attention and undergoes a clinical examination by an experienced clinician.
A second experienced clinician then reviews the clinical diagnosis.
If the diagnosis agrees, it is considered the gold standard.
If there is a discrepancy in the diagnosis, the consensus between the two clinicians is used as the gold standard.
|
|
Patients with Eye-related Chief Complaints
Individuals who have specific concerns or issues related to their eyes, which they consider as the main reason for seeking medical attention or making a complaint.
|
Multimodal Vision-language Model for Multi-task Diagnosis and Triage Suggestions of Ophthalmic Diseases Patients presenting with complaints of anterior segment diseases first complete a slit-lamp examination or take a mobile phone eye photograph.
A multimodal vision-language model uses patient-related images (such as selfies and eye exam photos) to make an intelligent diagnosis.
The diagnosis is kept private.
The patient then seeks medical attention and undergoes a clinical examination by an experienced clinician.
A second experienced clinician then reviews the clinical diagnosis.
If the diagnosis agrees, it is considered the gold standard.
If there is a discrepancy in the diagnosis, the consensus between the two clinicians is used as the gold standard.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic accuracy of multimodal vision-language model.
Time Frame: from July 2025 to September 2025
|
For each patient, the diagnoses generated by the multimodal vision-language model and the clinical diagnosis provided by skilled clinicians were documented and compared.
Consistency between the two diagnoses indicates the program's precision in clinical practice.
|
from July 2025 to September 2025
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 28, 2025
Primary Completion (Estimated)
November 20, 2027
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
February 25, 2026
First Submitted That Met QC Criteria
February 25, 2026
First Posted (Actual)
March 4, 2026
Study Record Updates
Last Update Posted (Actual)
March 5, 2026
Last Update Submitted That Met QC Criteria
March 3, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- U24A20707
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anterior Segment Diseases
-
Heidelberg Engineering GmbHActive, not recruitingEyes With Normal Anterior Segment | Eyes With Abnormal Anterior SegmentUnited States
-
Heidelberg Engineering GmbHTerminatedEyes with Normal Anterior Segment | Eyes with Abnormal Anterior SegmentUnited States
-
Lightfield MedicalCompletedAnterior Segment of EyeUnited States
-
Sun Yat-sen UniversityUnknownArtificial Intelligence | Anterior Segment DisordersChina
-
Institut National de la Santé Et de la Recherche...RecruitingMicrophthalmia | Aniridia | Anophthalmia | Anterior Segment Dysgenesis 6, Peters Anomaly Subtype | Anterior Segment Dysgenesis 3, Rieger SubtypeFrance
-
Yune ZhaoUnknownPhacoemulsification | Anterior Chamber Parameters | Anterior Segment Swept-source Optical Coherence TomographyChina
-
Fondation Ophtalmologique Adolphe de RothschildMinistry of Health, FranceCompletedAmbulatory Surgical Procedures | Ocular Anterior Segment SurgeryFrance
-
Tishreen UniversityCompletedMild to Moderate Anterior Mandibular Segment CrowdindSyrian Arab Republic
-
Cairo UniversityRecruitingFentanyl | Adjuvant | Ketorolac | Peribulbar Block | Anterior Segment SurgeriesEgypt
-
Massachusetts General HospitalCompletedMeasurement of the Elasticity of the Anterior Eye SegmentUnited States
Clinical Trials on Multimodal Vision-language Model Diagnosis
-
Peking University Third HospitalQingdao Municipal Hospital; Tianjin Medical University General Hospital; The... and other collaboratorsRecruitingHeart Failure With Preserved Ejection FractionChina
-
Capital Medical UniversityCompleted
-
Second Affiliated Hospital of Nanchang UniversityFirst Affiliated Hospital of Zhejiang University; Renmin Hospital of Wuhan... and other collaboratorsRecruitingHemorrhage StrokeChina
-
University of ManitobaRecruitingContraception | VasectomyCanada
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingMedical Artificial Intelligence | Interdisciplinary Research | Self-Directed LearningChina
-
Philipps University MarburgRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityCompletedNon-emergency Ocular DiseasesChina
-
John J ChenCompletedCommunication | Interdisciplinary Communication | Artificial Intelligence (AI) | Artificial Intelligence TechnologyUnited States
-
Shandong Cancer Hospital and InstituteNot yet recruiting
-
Yale UniversityUniversity of Pennsylvania; George Washington University; World Bank; EHA Clinics...Completed